Purchase Order W912D124P0013

Award Date 9/3/24
Potential Completion Date 10/18/24
Potential Value $165K
Funding Federal Agency
Department of the Army
Contracting Federal Agency
RCO Kuwait 408th CSB
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Qatar
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of the Army awarded a $136,500 firm fixed price blanket purchase agreement (BPA) call contract to Al Itqaan Contracting Maintenance And Trading EST for anti-venom products and services in support of U.S. Army Medical Materiel Center operations in Qatar. The contract has a period of performance through June 30, 2022 with no set-aside designation applied. Al Itqaan will provide anti-venom supplies under this contract to support U.S. military medical readiness and operations at...
The Department of the Army Medical Command awarded a $251,820 firm fixed price purchase order to Tryco Incorporated for the supply of 36 boxes of Polyserp Pan-Africa Antivenom or equal product. The solicitation sought quotes to provide antivenom covering 25 African snake species, in freeze-dried form stable up to 40 degrees Celsius for six months. Delivery of the antivenom was required by July 20, 2023 to a location in Kaiserslautern, Germany. There was no set-aside designation. Tryco will...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $40,808.96 firm fixed-price contract is for the procurement of IMOVAX Rabies Vaccine Vials, with a completion date of June 26, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $98,169.12, is for the delivery of rabies vaccines. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,292.02 firm-fixed-price delivery order is for the supply of IMOGAM RABIES-HT 150 UNIT/ML 2ML, a specialized medication. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,299.36 firm fixed-price delivery order is for the provision of IMOGAM RABIES-HT 150 UNIT/ML 2ML, a medical product used for rabies prevention. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $7,428.66, is a Delivery Order for Rabies Vaccine 2.5 1S. The contract has an ultimate completion date of April 4, 2025 and is a Firm Fixed Price contract type. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for the supply of IMOVAX Rabies Vaccine vials, with a firm fixed-price ceiling of $51,998.82 and an ultimate completion date of August 19, 2024. The contract has no set-aside designation. This order is likely part of a broader Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award, valued at $41,133.78, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of IMOVAX Rabies Vaccine Vials to support military healthcare programs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This federal contract award is for the delivery of POLYSERP-P snake antivenom to the Department of the Army Medical Command. The $125,910.00 firm fixed price purchase order was awarded to Tryco Incorporated, a woman-owned small business that specializes in distributing medical and dental supplies to the federal government. Tryco has a history of delivering a variety of medical equipment and supplies to Department of Veterans Affairs, Defense Health Agency, and Army Medical Command facilities....

This firm fixed price purchase order contract, valued at $164,523.15, was awarded by the Department of the Army to Al Itqaan Contracting Maintenance And Trading EST, a for-profit organization based in Qatar. The contract is for the delivery of Razi Polyvalent Snake Anti-Venom to support U.S. military operations in Qatar and the Middle East.

The contract has an ultimate completion date of October 18, 2024 and was awarded on September 3, 2024. It is not designated as a set-aside contract. In addition to this purchase order, Al Itqaan holds a single award blanket purchase agreement (BPA) with the Department of the Army, valued at up to $273,000, to provide anti-venom and other medical supplies to Army facilities in Qatar through June 2023. The BPA facilitates rapid acquisition of critical medical countermeasures to support ongoing military medical readiness and treatment operations in the region.

Generated 3/29/25, 9:59 AM